| Patricia Heath Anderson, CRNA | |
|
1144 N Road St, Elizabeth City, NC 27909-3353 | |
| (252) 335-0531 | |
| Not Available |
| Full Name | Patricia Heath Anderson |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 1144 N Road St, Elizabeth City, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811948763 | NPI | - | NPPES |
| 8051130 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 066693 (North Carolina) | Primary |
| Entity Name | Nurse Anesthesia Of North Carolina Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689628729 PECOS PAC ID: 7911806195 Enrollment ID: O20040107000364 |
News Archive
Ibrutinib is a drug for the treatment of rare diseases. It has been approved for the treatment of adults with chronic lymphocytic leukaemia (CLL) or with relapsed or refractory mantle cell lymphoma (MCL) since 2014, and since 2015 also for the treatment of adults with Waldenström macroglobulinaemia. Regarding the treatment of patients with CLL or MCL, the Federal Joint Committee (G-BA) already conducted a benefit assessment and made a decision in 2015.
A new Medicare rule limiting payments for oxygen providers is prompting an aggressive lobbying campaign by the industry, and unintended consequences for patients, the Cleveland Plain Dealer reports:
It is unclear whether patients with neurogenic bladder disorders benefit from the drug L-methionine. The only study currently available provides neither proof of benefit nor proof of harm. This is the result of a report published by the German Institute for Quality and Efficiency in Health Care (IQWiG) on 12 July 2010.
A kidney transplantation means much more than good health to Jason E. Jones. The 53 year-old Hyde Park artist and Loyola Medicine patient draws daily creative inspiration from his chronic health experience.
Researchers from Universidad Politécnica de Madrid have obtained 3D printed floating photocatalysts to remove persistent pollutants in wastewater.
› Verified 5 days ago
| Entity Name | Carolina Anesthesia Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699723791 PECOS PAC ID: 1456251057 Enrollment ID: O20040115000938 |
News Archive
Ibrutinib is a drug for the treatment of rare diseases. It has been approved for the treatment of adults with chronic lymphocytic leukaemia (CLL) or with relapsed or refractory mantle cell lymphoma (MCL) since 2014, and since 2015 also for the treatment of adults with Waldenström macroglobulinaemia. Regarding the treatment of patients with CLL or MCL, the Federal Joint Committee (G-BA) already conducted a benefit assessment and made a decision in 2015.
A new Medicare rule limiting payments for oxygen providers is prompting an aggressive lobbying campaign by the industry, and unintended consequences for patients, the Cleveland Plain Dealer reports:
It is unclear whether patients with neurogenic bladder disorders benefit from the drug L-methionine. The only study currently available provides neither proof of benefit nor proof of harm. This is the result of a report published by the German Institute for Quality and Efficiency in Health Care (IQWiG) on 12 July 2010.
A kidney transplantation means much more than good health to Jason E. Jones. The 53 year-old Hyde Park artist and Loyola Medicine patient draws daily creative inspiration from his chronic health experience.
Researchers from Universidad Politécnica de Madrid have obtained 3D printed floating photocatalysts to remove persistent pollutants in wastewater.
› Verified 5 days ago
| Entity Name | Coastal Healthcare Resources Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467635128 PECOS PAC ID: 1658283593 Enrollment ID: O20090929000052 |
News Archive
Ibrutinib is a drug for the treatment of rare diseases. It has been approved for the treatment of adults with chronic lymphocytic leukaemia (CLL) or with relapsed or refractory mantle cell lymphoma (MCL) since 2014, and since 2015 also for the treatment of adults with Waldenström macroglobulinaemia. Regarding the treatment of patients with CLL or MCL, the Federal Joint Committee (G-BA) already conducted a benefit assessment and made a decision in 2015.
A new Medicare rule limiting payments for oxygen providers is prompting an aggressive lobbying campaign by the industry, and unintended consequences for patients, the Cleveland Plain Dealer reports:
It is unclear whether patients with neurogenic bladder disorders benefit from the drug L-methionine. The only study currently available provides neither proof of benefit nor proof of harm. This is the result of a report published by the German Institute for Quality and Efficiency in Health Care (IQWiG) on 12 July 2010.
A kidney transplantation means much more than good health to Jason E. Jones. The 53 year-old Hyde Park artist and Loyola Medicine patient draws daily creative inspiration from his chronic health experience.
Researchers from Universidad Politécnica de Madrid have obtained 3D printed floating photocatalysts to remove persistent pollutants in wastewater.
› Verified 5 days ago
| Entity Name | Carolina Regional Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891072609 PECOS PAC ID: 5496921769 Enrollment ID: O20120109000406 |
News Archive
Ibrutinib is a drug for the treatment of rare diseases. It has been approved for the treatment of adults with chronic lymphocytic leukaemia (CLL) or with relapsed or refractory mantle cell lymphoma (MCL) since 2014, and since 2015 also for the treatment of adults with Waldenström macroglobulinaemia. Regarding the treatment of patients with CLL or MCL, the Federal Joint Committee (G-BA) already conducted a benefit assessment and made a decision in 2015.
A new Medicare rule limiting payments for oxygen providers is prompting an aggressive lobbying campaign by the industry, and unintended consequences for patients, the Cleveland Plain Dealer reports:
It is unclear whether patients with neurogenic bladder disorders benefit from the drug L-methionine. The only study currently available provides neither proof of benefit nor proof of harm. This is the result of a report published by the German Institute for Quality and Efficiency in Health Care (IQWiG) on 12 July 2010.
A kidney transplantation means much more than good health to Jason E. Jones. The 53 year-old Hyde Park artist and Loyola Medicine patient draws daily creative inspiration from his chronic health experience.
Researchers from Universidad Politécnica de Madrid have obtained 3D printed floating photocatalysts to remove persistent pollutants in wastewater.
› Verified 5 days ago
| Entity Name | Coastal Carolina Sedation Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114544996 PECOS PAC ID: 2961829825 Enrollment ID: O20200824003565 |
News Archive
Ibrutinib is a drug for the treatment of rare diseases. It has been approved for the treatment of adults with chronic lymphocytic leukaemia (CLL) or with relapsed or refractory mantle cell lymphoma (MCL) since 2014, and since 2015 also for the treatment of adults with Waldenström macroglobulinaemia. Regarding the treatment of patients with CLL or MCL, the Federal Joint Committee (G-BA) already conducted a benefit assessment and made a decision in 2015.
A new Medicare rule limiting payments for oxygen providers is prompting an aggressive lobbying campaign by the industry, and unintended consequences for patients, the Cleveland Plain Dealer reports:
It is unclear whether patients with neurogenic bladder disorders benefit from the drug L-methionine. The only study currently available provides neither proof of benefit nor proof of harm. This is the result of a report published by the German Institute for Quality and Efficiency in Health Care (IQWiG) on 12 July 2010.
A kidney transplantation means much more than good health to Jason E. Jones. The 53 year-old Hyde Park artist and Loyola Medicine patient draws daily creative inspiration from his chronic health experience.
Researchers from Universidad Politécnica de Madrid have obtained 3D printed floating photocatalysts to remove persistent pollutants in wastewater.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Patricia Heath Anderson, CRNA 653 Owens Ct, Wilmington, NC 28412-0953 Ph: (252) 335-0531 | Patricia Heath Anderson, CRNA 1144 N Road St, Elizabeth City, NC 27909-3353 Ph: (252) 335-0531 |
News Archive
Ibrutinib is a drug for the treatment of rare diseases. It has been approved for the treatment of adults with chronic lymphocytic leukaemia (CLL) or with relapsed or refractory mantle cell lymphoma (MCL) since 2014, and since 2015 also for the treatment of adults with Waldenström macroglobulinaemia. Regarding the treatment of patients with CLL or MCL, the Federal Joint Committee (G-BA) already conducted a benefit assessment and made a decision in 2015.
A new Medicare rule limiting payments for oxygen providers is prompting an aggressive lobbying campaign by the industry, and unintended consequences for patients, the Cleveland Plain Dealer reports:
It is unclear whether patients with neurogenic bladder disorders benefit from the drug L-methionine. The only study currently available provides neither proof of benefit nor proof of harm. This is the result of a report published by the German Institute for Quality and Efficiency in Health Care (IQWiG) on 12 July 2010.
A kidney transplantation means much more than good health to Jason E. Jones. The 53 year-old Hyde Park artist and Loyola Medicine patient draws daily creative inspiration from his chronic health experience.
Researchers from Universidad Politécnica de Madrid have obtained 3D printed floating photocatalysts to remove persistent pollutants in wastewater.
› Verified 5 days ago
John Martin Whalen, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1144 N Road St, Elizabeth City, NC 27909 Phone: 252-335-0531 | |
Brian M Carroll, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1144 N Road St, Elizabeth City, NC 27909 Phone: 252-335-0531 | |
William J Weast, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 1144 N Road St, Elizabeth City, NC 27909 Phone: 252-335-0531 | |
Jill H Robertson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1144 N Road St, Elizabeth City, NC 27909 Phone: 252-335-0531 | |
Eric David Mcnaughton, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1144 N Road St, Elizabeth City, NC 27909 Phone: 252-335-0531 | |
Sharon Iannotte, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1144 N Road St, Elizabeth City, NC 27909 Phone: 252-335-0531 | |
Jane F Schneider, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1144 N Road St, Elizabeth City, NC 27909 Phone: 252-335-0531 |